Innovation Pharmaceuticals Inc. (IPIX) SEC Filing 8-K Material Event for the period ending Tuesday, October 23, 2018

Innovation Pharmaceuticals Inc.

CIK: 1827328 Ticker: IPIX

View differences made from one to another to evaluate Innovation Pharmaceuticals Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Innovation Pharmaceuticals Inc..


Assess how Innovation Pharmaceuticals Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Innovation Pharmaceuticals Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: IPIX
CIK: 1355250
Form Type: 8-K Corporate News
Accession Number: 0001477932-18-004994
Submitted to the SEC: Wed Oct 24 2018 7:00:22 AM EST
Accepted by the SEC: Wed Oct 24 2018
Period: Tuesday, October 23, 2018
Industry: Pharmaceutical Preparations
  1. Regulated Disclosure

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: